Lian Bai Selected Research

Lian Bai Research Topics

Disease

5	Neoplasms (Cancer) 05/2020 - 11/2014
4	Rectal Neoplasms (Rectal Cancer) 12/2021 - 01/2021
2	Leukemia 11/2022 - 02/2022
2	Subcutaneous Emphysema 01/2022 - 01/2017
2	Pneumoperitoneum 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 05/2020 - 06/2018
2	Type 2 Diabetes Mellitus (MODY) 12/2019 - 01/2014
1	Vomiting 08/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Nausea 01/2021
1	Leukopenia 01/2021
1	Obesity 08/2020
1	Intestinal Polyps 05/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2018
1	Pain (Aches) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 09/2016
1	Liver Neoplasms (Liver Cancer) 09/2016
1	Stomach Neoplasms (Stomach Cancer) 07/2016
1	Diabetes Mellitus 11/2014
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2014
1	Necrosis 11/2014
1	Hypoglycemia (Reactive Hypoglycemia) 01/2014
1	Body Weight (Weight, Body) 01/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 08/2020 - 11/2014
2	Carbon DioxideIBA 01/2022 - 01/2017
2	Nitrous Oxide (Laughing Gas)IBA 01/2022 - 01/2017
2	NitrogenIBA 01/2022 - 01/2017
2	HeliumIBA 01/2022 - 01/2017
2	GasesIBA 01/2022 - 01/2017
2	ArgonIBA 01/2022 - 01/2017
2	MicroRNAs (MicroRNA)IBA 12/2019 - 09/2016
2	Biomarkers (Surrogate Marker)IBA 06/2018 - 09/2016
1	Bevacizumab (Avastin)FDA Link 02/2022
1	Tropisetron (Navoban)IBA 08/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2021
1	EmulsionsIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Decitabine FDA Link 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2021
1	AdipokinesIBA 08/2020
1	Bacteriocins (Lantibiotics)IBA 08/2020
1	InflammasomesIBA 08/2020
1	Cell-Free Nucleic AcidsIBA 05/2020
1	sterol carrier proteinsIBA 12/2019
1	Chimeric Antigen ReceptorsIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 06/2018
1	Racemases and Epimerases (Epimerases and Racemases)IBA 06/2018
1	Coenzyme A (CoA)IBA 06/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2018
1	Fluorouracil (Carac)FDA LinkGeneric 07/2016
1	Pharmaceutical PreparationsIBA 07/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2016
1	Small Interfering RNA (siRNA)IBA 07/2016
1	LuciferasesIBA 07/2016
1	TensinsIBA 07/2016
1	Phosphates (Orthophosphate)IBA 11/2014
1	Liraglutide FDA Link 11/2014
1	BuffersIBA 11/2014
1	Chemotactic FactorsIBA 11/2014
1	Glucose (Dextrose)FDA LinkGeneric 11/2014
1	Messenger RNA (mRNA)IBA 11/2014
1	glimepiride (Amarel)FDA LinkGeneric 01/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2014
1	Acarbose FDA LinkGeneric 01/2014
1	Blood Glucose (Blood Sugar)IBA 01/2014
1	VildagliptinIBA 01/2014
1	Pioglitazone (Actos)FDA Link 01/2014
1	IncretinsIBA 01/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2014
1	saxagliptin FDA Link 01/2014

Therapy/Procedure

4	Therapeutics 11/2022 - 01/2014
3	Drug Therapy (Chemotherapy) 02/2022 - 01/2021
1	Radiotherapy 12/2021
1	Chemoradiotherapy 12/2021
1	Salvage Therapy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Injections 01/2021